Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
The post Biolinq Snags $58M for ‘Smallest Biosensor in the World’ appeared first on MedCity News.
Related Articles
Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing?
During a recent panel discussion, three healthcare experts discussed reasons why value-based...
Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing?
During a recent panel discussion, three healthcare experts discussed reasons why value-based...
State Reported Efforts to Address Health Disparities: A 50 State Review
This analysis focuses on current state efforts, many of which were implemented...
State Reported Efforts to Address Health Disparities: A 50 State Review
This analysis focuses on current state efforts, many of which were implemented...
Leave a comment